COMVITA LIMITED 26 April 2016
Comvita Director Resignation
Edward (Ed) Quilty has tendered his resignation from the Board of Comvita Limited, effective immediately.
Ed was first appointed to be a director of Comvita Limited when Derma Sciences, Inc., Comvita'sUSA based woundcare partner, became a significant shareholder in Comvita in August 2013.
Ed resigned as the Chief Executive Officer of Derma at the end of 2015. With his resignation from Derma in the US, it was agreed by the Comvita Board that it was no longer appropriate for Ed to continue as a director on the Comvita Board.
The Board is grateful to Ed for his contribution, particularly as it related to keeping an ongoing strong relationship with Derma. Sales of Medihoney branded woundcare products by Derma to hospitals and professionals now account for circa US$20m per annum and growing, realising a continuing royalty stream for Comvita.
Ends
For further information:
Scott Coulter, Comvita CEO, 021 386 988
Neil Craig, Comvita Chairman, 021 731 509
Julie Chadwick, Comvita Communications Manager, 021 510 693
Background information
About Comvita (www.comvita.com)
Comvita (NZX:CVT) is a global natural health company committed to the development of innovative products, backed by ongoing investment in scientific research.
Comvita Limited issued this content on 26 April 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 26 April 2016 07:07:24 UTC
Original Document: http://www.comvita.co.nz/_assets/Investors/Financial-News/Year-ended-31-March-2016/CVT_Director_Resignation-Ed_Quilty.pdf
